PallisgaardJLSchjerningAMLindhardtTBet al.Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study. Eur J Prev Cardiol2016; 23: 621–627.
2.
HobbsFRTaylorCJJan GeersingGet al.European Primary Care Cardiovascular Society (EPCCS) SPAF working group. European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care. Eur J Prev Cardiol2016; 23: 460–473.
3.
MonteSMacchiaAPellegriniFet al.Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation. Eur Heart J2006; 27: 2217–2223.
4.
GranzieraSBertozzoGPengoVet al.To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): Results from the VENPAF cohort. Intern Emerg Med2015; 10: 795–804.
5.
PoliD1AntonucciETestaSet al.Italian Federation of Anticoagulation Clinics. Bleeding risk in very old patients on vitamin K antagonist treatment: Results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation. Circulation2011; 124: 824–829.
6.
Di PasqualeGMathieuGMaggioniAPet al.Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: The ATA-AF study. Int J Cardiol2013; 167: 2895–2903.
7.
LefebvreMCSt-OngeMGlazer-CavanaghMet al.The effect of bleeding risk and frailty status on anticoagulation patterns in octogenarians with atrial fibrillation: The FRAIL-AF study. Can J Cardiol2016; 32: 169–176.
8.
PoliDAntonucciEGrifoniEet al.Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years. J Am Coll Cardiol2009; 54: 999–1002.
9.
TomlinAMLloydHSTilyardMW. Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk. Eur J Prev Cardiol2017; 24: 311–319.
10.
MarcucciMIorioANobiliAet al.REPOSI Investigators. Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards. Eur J Intern Med2010; 21: 516–523.
11.
BahriORocaFLechaniTet al.Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in France: Comparisons of resident characteristics and physician attitude. J Am Geriatr Soc2015; 63: 71–76.
12.
MaesFDalleurOHenrardSet al.Risk scores and geriatric profile: Can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?Clin Interv Aging2014; 9: 1091–1099.
13.
HanonOVidalJSLe HeuzeyJYet al.Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF. Int J Cardiol2017; 232: 98–104.
